Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00148408 · ClinicalTrials.gov registry record · Phase 4

Trial of Asthma Patient Education (TAPE)

A Phase 4 study, sponsored by American Lung Association Asthma Clinical Research Centers.

Completed
Registry status
Phase 4
Development phase
600
Enrollment target

NCT00148408: Completed Phase 4 study, sponsored by American Lung Association Asthma Clinical Research Centers.

NCT00148408 is a Phase 4 study that has completed, run by American Lung Association Asthma Clinical Research Centers. The registered enrollment target is 600 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00148408, a Phase 4 study, has completed, sponsored by American Lung Association Asthma Clinical Research Centers.

COMPLETED
Registry status
Phase 4
Development phase
600 participants
Enrollment target

Study Summary

The purpose of this research study is to investigate the way that educational approaches and presentation of a drug may affect the response to montelukast and placebo (an inactive medication) in subjects with asthma.

Interventions

  • DRUG Montelukast
  • BEHAVIORAL Education

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2003-12
Est. Completion 2005-12
Phase Phase 4

What the finished NCT00148408 record still lists

NCT00148408 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (16% higher).

The record links to 0 conditions, and to 2 interventions - of which Montelukast is the first listed.

NCT00148408 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00148408 about?

NCT00148408 is a clinical study titled "Trial of Asthma Patient Education (TAPE)". The purpose of this research study is to investigate the way that educational approaches and presentation of a drug may affect the response to montelukast and placebo (an inactive medication) in subjects with asthma.

What is the current status of trial NCT00148408?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 600 participants. The study started on 2003-12. Estimated completion is 2005-12.

What interventions are being tested in trial NCT00148408?

The interventions under investigation include: Montelukast (DRUG), Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT00148408?

This trial is sponsored by American Lung Association Asthma Clinical Research Centers, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00148408's enrollment target sits among peer trials

600 137th of 2000 higher than 1,854 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00148408, the US trial registry maintained by the National Library of Medicine. NCT00148408 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.